Association between SGLT2 inhibitor use and risk of sepsis-induced cardiomyopathy in patients with type 2 diabetes: a propensity-matched cohort study
Among patients with T2D and sepsis, SGLT2is were associated with a lower risk of SICM and improved long-term cardiovascular outcomes, compared to DPP4is therapy. These results support further prospective studies to validate the role of SGLT2is in preventing SICM.
Authors
- Tsung Yu (ORCID: https://orcid.org/0000-0002-5773-3665)
- Chia‐Li Kao
- Kuan‐Jui Tseng
- Jheng‐Yan Wu (ORCID: https://orcid.org/0000-0002-3290-1909)
- Kuo-Chuan Hung (ORCID: https://orcid.org/0000-0002-4507-8085)
- Yu‐Min Lin (ORCID: https://orcid.org/0000-0002-7011-2986)
Institutions
- E-Da Hospital (TW)
- Chi Mei Medical Center (TW)
- National Cheng Kung University (TW)
- I-Shou University (TW)
Publication Details
- Journal
- Critical Care
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1186/s13054-025-05685-0
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88